Involvement of G-463A MPO gene polymorphism in the response of postmenopausal women to hormone therapy

作者：Ruiz del Agua Ainhoa; Aurrekoetxea Igor; Angel Elorriaga Miguel; Rodriguez Fernando; Gueraud Francoise; Begona Ruiz Larrea M; Ignacio Ruiz Sanz Jose

来源：Menopause-The Journal of the North American Menopause Society, 2011, 18(5): 575-581.

DOI：10.1097/gme.0b013e3181fcabaa

• MPO gene
• Single-nucleotide polymorphism
• Menopause
• Hormone therapy
• Human

Objective: The aims of this work were to determine (1) the effects of estrogen plus progestogen therapy (EPT) and raloxifene on oxidative stress and cardiovascular risk biomarkers in postmenopausal women and (2) the involvement of the functional G-463A polymorphism of the myeloperoxidase (MPO) gene in the therapy responses.
Methods: Postmenopausal women (45-55 y old) were assigned to three groups receiving (1) EPT (continuous 50 mu g transdermal estradiol daily and 200 mg/d micronized progesterone orally the first 14 d of each month; n = 21), (2) raloxifene (60 mg daily; n = 17), and (3) no treatment (control; n = 21). Blood and urine samples were taken before and after 6 months of therapy. Measurements were serum lipid profile, C-reactive intercellular adhesion molecule 1 (ICAM-1), alpha-tocopherol, gamma-tocopherol, uric acid, total antioxidant activity (TAA), malondialdehyde, and urinary 1,4-dihydroxynonane-mercapturic acid (the major urinary 4-hydroxynonenal metabolite). The G-463A MPO polymorphism was analyzed by polymerase chain reaction and restriction fragment length polymorphism.
Results: EPT significantly decreased TAA and the levels of ICAM-1, not modifying other cardiovascular risk or oxidative stress markers. The raloxifene and control groups experienced no modifications in oxidative stress or endothelial dysfunction markers. The MPO genotype specifically influenced the outcomes in the EPT group. Thus, TAA decreased significantly in GG (high-expression genotype) homozygotes, whereas ICAM-1 levels were reduced in A allele carriers.
Conclusions: EPT exerted a negative action on the serumoxidant/antioxidant balance in the MPO GG homozygotes and a positive effect on the ICAM-1 endothelial dysfunction marker in carriers of the low-expression A allele. This observation provides evidence of the importance of this polymorphism in the response to EPT.

• 出版日期2011-5